UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000022469 |
|---|---|
| Receipt number | R000025892 |
| Scientific Title | The retrospective study of antithrombotic therapies in cardiovascular diseases to elucidate the clinical problems and to develop management strategies. |
| Date of disclosure of the study information | 2016/06/27 |
| Last modified on | 2017/02/09 16:26:49 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
The retrospective study of antithrombotic therapies in cardiovascular diseases to elucidate the clinical problems and to develop management strategies.
Acronym
The retrospective study of antithrombotic therapies in cardiovascular diseases to elucidate the clinical problems and to develop management strategies.
Scientific Title
The retrospective study of antithrombotic therapies in cardiovascular diseases to elucidate the clinical problems and to develop management strategies.
Scientific Title:Acronym
The retrospective study of antithrombotic therapies in cardiovascular diseases to elucidate the clinical problems and to develop management strategies.
Region
| Japan |
Condition
Condition
Cardiovascular diseases
Classification by specialty
| Cardiology |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
The aim of this study is to elucidate appropriate strategies of antithrombotic therapies in patients with atrial fibrillation and other cardiovascular diseases. To do this, we will retrospectively evaluate both thromboembolic and bleeding events associated with antithrombotic therapies in patients enrolled in the Chronic Heart Failure Analysis and Registry in the Tohoku District 2 (CHART-2) study (NCT00418041, UMIN000000562). Also, the result will be compared with other large-scale cohort studies conducted in Japan.
Basic objectives2
Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Thromboembolic and bleeding events associated with antithrombotic therapies
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
Atrial fibrillation/atrial flutter, and other cardiovascular diseases
Key exclusion criteria
Not applicable
Target sample size
33700
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Hiroaki Shimokawa |
Organization
Tohoku University Graduate School of Medicine
Division name
Department of Cardiovascular Medicine
Zip code
Address
1-1 Seiryo-machi, Aoba-ku, Sendai 980-8574, Japan
TEL
+81-22-717-7153
shimo@cardio.med.tohoku.ac.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Yasuhiko Sakata |
Organization
Tohoku University Graduate School of Medicine
Division name
Department of Cardiovascular Medicine
Zip code
Address
1-1 Seiryo-machi, Aoba-ku, Sendai 980-8574, Japan
TEL
+81-22-717-7153
Homepage URL
sakatayk@cardio.med.tohoku.ac.jp
Sponsor or person
Institute
Departments of Cardiovascular Medicine and Evidence-based Cardiovascular Medicine, Tohoku University Graduate School of Medicine / Tohoku Heart Failure Association
Institute
Department
Personal name
Funding Source
Organization
Japan Agency for Medical Research and Development
Organization
Division
Category of Funding Organization
Japanese Governmental office
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2016 | Year | 06 | Month | 27 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
No longer recruiting
Date of protocol fixation
| 2016 | Year | 05 | Month | 25 | Day |
Date of IRB
Anticipated trial start date
| 2016 | Year | 06 | Month | 27 | Day |
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Under analysis
Management information
Registered date
| 2016 | Year | 05 | Month | 26 | Day |
Last modified on
| 2017 | Year | 02 | Month | 09 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000025892
